Oxeia Biopharma named Most Innovative mTBI Biopharma Company 2025 by Global Health & Pharma

Written By Lindsey McClelland

Read more about what’s behind Global Health & Pharma’s selection of Oxeia BioPharma as the Most Innovative mTBI Biopharma Company 2025

Read More

Lindsey McClelland
Next

Neurotrauma Reports: Injection of Ghrelin (OXE-103) Improves Subacute Concussion Symptom Burden and Quality of Life